peptide 1 glp 1 receptor agonist glp-1_analogs [TUSOM Table 1 from Glucagon-Like Peptide-1
Description
However, the trade-off is less total weight loss

Khan D, Sridhar A, Moffett CR

They are approved only for type 2 diabetes and weight management under specific NICE guidance, and any use for inflammatory conditions would be considered off-label prescribing

Further studies exploring these aspects are needed

Obesity, particularly during puberty, plays a critical role in PCOS development
